Eli Lilly Stock Soars While Novo Nordisk Sinks—Why the Weight-Loss Leaders Are Headed in Opposite DirectionsInvestopedia • 02/04/26
Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026CNBC • 02/04/26
Eli Lilly Soars, Novo Nordisk Plummets On GLP/Obesity Updates - Here's What To DoSeeking Alpha • 02/04/26
Lilly Stock Jumps After Q4 Earnings Beat and Strong 2026 GuidanceZacks Investment Research • 02/04/26
Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026The Motley Fool • 02/04/26
Eli Lilly shares soar after Q4 beat, strong forecast on weight-loss drugsProactive Investors • 02/04/26
Eli Lilly Surges 9% After Obliterating Forecasts As Mounjaro, Zepbound Sales DoubleInvestors Business Daily • 02/04/26
Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soarCNBC • 02/04/26